Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Inoue

Showing results (501-510 of 561) with videos related to

Pageof 57
Sort By:
Journal of Gastrointestinal Cancer|June 12, 2020
Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute ExperienceKazuma Kobayashi, Kengo Kanetaka, Akira Yoneda, et al.
Frontiers in Oncology|March 13, 2023
LOXL1 and LOXL4 are novel target genes of the Zn<sup>2+</sup>-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cellsDaisuke Hirabayashi, Ken-Ichi Yamamoto, Akihiro Maruyama, et al.
European Journal of Pharmacology|August 22, 2017
A novel partial agonist of GPBA reduces blood glucose level in a murine glucose tolerance testRina Enomoto, Aya Kurosawa, Yoshiaki Nikaido, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Respiratory Medicine|November 23, 2024
Factors associated with uncontrolled severe asthma in the biologic eraHideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Scientific Reports|October 22, 2024
Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2Hitomi Kinoshita, Tsukasa Yamamoto, Yudai Kuroda, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
Oncology Letters|July 12, 2017
Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgeneEndy Widya Putranto, Rie Kinoshita, Masami Watanabe, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 25, 2025
Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trialChikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
Pageof 57

Showing results (501-510 of 561) with videos related to

Sort By:
Pageof 57
Journal of Gastrointestinal Cancer|June 12, 2020
Downstaging and Histological Effects Might Be Reliable Predictors of the Efficacy of DOC+CDDP+5-FU (DCF) as Neoadjuvant Therapy for Stage III or Borderline Resectable Esophageal Cancer: a Single Institute ExperienceKazuma Kobayashi, Kengo Kanetaka, Akira Yoneda, et al.
Frontiers in Oncology|March 13, 2023
LOXL1 and LOXL4 are novel target genes of the Zn<sup>2+</sup>-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cellsDaisuke Hirabayashi, Ken-Ichi Yamamoto, Akihiro Maruyama, et al.
European Journal of Pharmacology|August 22, 2017
A novel partial agonist of GPBA reduces blood glucose level in a murine glucose tolerance testRina Enomoto, Aya Kurosawa, Yoshiaki Nikaido, et al.
BMC Pulmonary Medicine|October 3, 2021
Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with uncommon histology: a propensity-score-matched analysisKoichi Miyashita, Masato Karayama, Yusuke Inoue, et al.
Respiratory Medicine|November 23, 2024
Factors associated with uncontrolled severe asthma in the biologic eraHideki Yasui, Kyohei Oishi, Fumiya Nihashi, et al.
Scientific Reports|October 22, 2024
Improved efficacy of SARS-CoV-2 isolation from COVID-19 clinical specimens using VeroE6 cells overexpressing TMPRSS2 and human ACE2Hitomi Kinoshita, Tsukasa Yamamoto, Yudai Kuroda, et al.
Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.
Oncology Letters|July 12, 2017
Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgeneEndy Widya Putranto, Rie Kinoshita, Masami Watanabe, et al.
Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 25, 2025
Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trialChikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
Pageof 57